[The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].

Authors
Category Primary study
JournalVoprosy onkologii
Year 2004
The effect of dicarbamin on the hemopoetic cells of the bone marrow of ovarian cancer patients receiving myelosuppressive combination chemotherapy (cyclophosphamide + carboplatin) is discussed.
Epistemonikos ID: 008ec7e31dcc4c49c8985b85182eab0f310408aa
First added on: Sep 13, 2023